Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, Furukawa T, Nara M, Akashi K, Taniguchi S, Harada M, Matsuo K, Teshima T; Japan Study Group for Cell Therapy and Transplantation (JSCT). Sugita J, et al. Among authors: kagaya y. Bone Marrow Transplant. 2019 Mar;54(3):432-441. doi: 10.1038/s41409-018-0279-1. Epub 2018 Aug 7. Bone Marrow Transplant. 2019. PMID: 30087460 Clinical Trial.
Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.
Kawashima N, Inamoto Y, Sato T, Nakashima M, Kagaya Y, Watakabe K, Seto A, Fukushima N, Kurahashi S, Ozawa Y, Miyamura K. Kawashima N, et al. Among authors: kagaya y. Bone Marrow Transplant. 2016 Jun;51(6):869-71. doi: 10.1038/bmt.2016.15. Epub 2016 Feb 15. Bone Marrow Transplant. 2016. PMID: 26878661 No abstract available.
Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M. Sato T, et al. Among authors: kagaya y. Bone Marrow Transplant. 2018 Oct;53(10):1359-1363. doi: 10.1038/s41409-018-0197-2. Epub 2018 May 8. Bone Marrow Transplant. 2018. PMID: 29740179 Clinical Trial. No abstract available.
A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.
Ando T, Sato T, Kurahashi S, Kawaguchi Y, Kagaya Y, Ozawa Y, Hirano S, Goto Y, Mano K, Yokoi S, Nakamura T, Murakami A, Noda S, Kimura S, Sone J, Kuru S, Sobue G, Katsuno M. Ando T, et al. Among authors: kagaya y. Nagoya J Med Sci. 2021 Aug;83(3):641-647. doi: 10.18999/nagjms.83.3.641. Nagoya J Med Sci. 2021. PMID: 34552296 Free PMC article.
[Bacillus cereus bacteremia in patients with hematological disorders].
Nakashima M, Osaki M, Goto T, Kagaya Y, Kawashima N, Morishita T, Ozawa Y, Miyamura K. Nakashima M, et al. Among authors: kagaya y. Rinsho Ketsueki. 2021;62(3):157-162. doi: 10.11406/rinketsu.62.157. Rinsho Ketsueki. 2021. PMID: 33828007 Japanese.
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
Kunou S, Shimada K, Takai M, Sakamoto A, Aoki T, Hikita T, Kagaya Y, Iwamoto E, Sanada M, Shimada S, Hayakawa F, Oneyama C, Kiyoi H. Kunou S, et al. Among authors: kagaya y. Oncogene. 2021 Jun;40(23):3989-4003. doi: 10.1038/s41388-021-01829-y. Epub 2021 May 16. Oncogene. 2021. PMID: 33994542 Free PMC article.
247 results